Inreda Diabetic
Eric Rikkert currently serves as the Chief Financial Officer at Inreda Diabetic, where the focus lies on developing an artificial pancreas that enhances the self-sufficiency and health monitoring of individuals with diabetes. Prior to this role, Eric was a member of the Board of Directors at Medisch Spectrum Twente, overseeing top-level clinical care. Eric has an extensive background in healthcare management, having worked as the General Director at SJG Weert and held various managerial positions, including Manager I&A and Project Manager EPD. Eric's earlier career includes roles such as Group Controller/ICT Manager at Roto Smeets Group and Manager of Process Organization & Control at Senefelder Misset B.V. Educational credentials comprise studies at the University of Amsterdam and Saxion University of Applied Sciences.
This person is not in any teams
Inreda Diabetic
1 followers
Inreda Diabetic is a fast growing company in the medical device industry. Inreda focuses on the development of the bi-hormonal fully closed loop system, also known as the Artifical Pancreas. This portable device regulates one’s blood glucose level autonomously, improving both quality of treatment and quality of life.